Source: International Congress 2014 – From bench to bronchiole: translational immunology and airways disease



Rating:

Share or cite this content

Citations should be made in the following way:
N. McElvaney (Dublin, Ireland). Translational immunology in genetic lung disease: advances in cystic fibrosis and Alpha-1 anti-trypsin deficiency. International Congress 2014 – From bench to bronchiole: translational immunology and airways disease

Member's Comments

No comment yet.

Related content which might interest you: Genetics, pathophysiology and diagnosis of Cystic fibrosis Source: ERS Skills Course 2016 Year: 2016 Practical microbiology of cystic fibrosis lung disease Source: School Course 2013 - Cystic Fibrosis Year: 2013 Genetics of fibrosing lung diseases Source: Eur Respir J 2005; 25: 915-927 Year: 2005 Investigating the role of cathepsin S in the pathogenesis of cystic fibrosis-like lung disease Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 Lung function in relation to emphysema development in alpha-1 antitrypsin deficiency Source: International Congress 2019 – Insights into physiological diagnostic services Year: 2019 Cystic fibrosis: prospects for therapy of some class 1 mutations Source: Annual Congress 2007 - Cystic fibrosis: will the new biology deliver? Year: 2007 CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways Source: Eur Respir Rev, 29 (156) 190068; 10.1183/16000617.0068-2019 Year: 2020 The pathogenesis of pulmonary fibrosis: a moving target Source: Eur Respir J 2013; 41: 1207-1218 Year: 2013 Pathophysiology of cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 1-13 Year: 2014 Proteasome function in lung fibrosis Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis Source: Eur Respir Rev 2012; 21: 48-56 Year: 2012 Clinical features of alpha one antitrypsin deficiency in non cystic fibrosis bronchiectasis Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Progress in the pathology of diffuse lung disease in infancy: changing concepts and diagnostic challenges Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=21 Year: 2007 Systems medicine advances in interstitial lung disease Source: Eur Respir Rev, 26 (145) 170021; 10.1183/16000617.0021-2017 Year: 2017 Increased levels of glycosaminoglycans in lungs from patients with IPF Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Update on pancreatic and liver disease in cystic fibrosis Source: Virtual Congress 2020 – Updates in cystic fibrosis Year: 2020 Mechanisms of liver disease in AATD Source: Eur Respir Monogr 2019; 85: 93-104 Year: 2019 Does apoptosis evasion only affect fibroblasts from idiopathic pulmonary fibrosis? Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 MiR-214-3p, a new fibromiR involved in the pathogenesis of idiopathic pulmonary fibrosis Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Stratified medicine: drugs meet genetics Source: Eur Respir Rev 2013; 22: 53-57 Year: 2013